COMMUNIQUÉS West-GlobeNewswire

-
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/05/2024 -
Monthly information on share capital and company voting rights
06/05/2024 -
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
06/05/2024 -
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
06/05/2024 -
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
06/05/2024 -
Helio Genomics to Showcase Results from CLiMB Pivotal Trial in an Oral Presentation at the EASL Congress 2024
06/05/2024 -
Aileron Therapeutics to Present at Two Upcoming Investor Conferences
06/05/2024 -
Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC
06/05/2024 -
Pennant Reports First Quarter 2024 Results
06/05/2024 -
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
06/05/2024 -
Sana Biotechnology to Present at May and June 2024 Investor Conferences
06/05/2024 -
Telesis Bio Announces Reverse Stock Split
06/05/2024 -
Regeneron Announces Investor Conference Presentations
06/05/2024 -
Shockwave Medical Reports First Quarter 2024 Financial Results
06/05/2024 -
NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024
06/05/2024 -
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
06/05/2024 -
RxSight, Inc. Reports First Quarter 2024 Financial Results
06/05/2024 -
LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
06/05/2024 -
Exagen Announces Campaign for Lupus Awareness Month
06/05/2024
Pages